Evidence map›Paper›PMID 32702084›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

The Temptation of Overgeneralizing Response-adaptive Randomization.

Sofía S Villar, David S Robertson, William F Rosenberger

Abstract readEditorialComment
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. A roadmap to using randomization in clinical trials.BMC medical research methodology · 2021
    Trial
  3. Article
  4. Article
  5. Review
  6. Response-adaptive randomization in clinical trials: from myths to practical considerations.Statistical science : a review journal of the Institute of Mathematical Statistics · 2023
    Article
  7. Article
  8. Article
  9. Reply to Villar et al.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  10. The Bayesian Design of Adaptive Clinical Trials.International journal of environmental research and public health · 2021
    Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Sofía S VillarMedical Research Council Biostatistics Unit, University of Cambridge, Institute of Public Health Forvie Site, Cambridge, United Kingdom.
David S RobertsonMedical Research Council Biostatistics Unit, University of Cambridge, Institute of Public Health Forvie Site, Cambridge, United Kingdom.ORCID 0000-0001-6207-0416
William F RosenbergerDepartment of Statistics, George Mason University, Fairfax, Virginia, USA.

Funding

STATISTICAL METHODOLOGY FOR CANCER CLINICAL TRIALSR01CA087746 · NCI · UNIVERSITY OF MARYLAND BALT CO CAMPUS · PI ROSENBERGER, WILLIAM F. · 2000 to 2004
$631k
Medical Research Council MC_UU_00002/15Medical Research Council MC_UU_00002/3Medical Research Council MC_UU_00002/6NCI NIH HHS R01 CA087746
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MotivationHumansRandom AllocationSample Size

Identifiers

PMID32702084
PMCPMC7614346

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.